March 27 (Reuters) - Cellmid Ltd CDY.AX :
* PRUDENT TO WITHDRAW PREVIOUS GUIDANCE THAT IT WILL ACHIEVE OPERATIONAL PROFITABILITY FOR ITS CONSUMER BUSINESS BY END OF FY2020
* JAPANESE BUSINESS EXPECTED TO DELIVER ON BUDGET FOR SECOND HALF OF 2020 FINANCIAL YEAR
* DELIVERY OF CHINESE EXPORT ORDER NOW EXPECTED TO OCCUR IN TWO SPERATE SHIPMENTS IN APRIL AND MAY 2020
* OPERATIONAL EXPENDITURE OF CO REDUCED WHERE SENSIBLE
* RECENTLY SECURED SUPPLY OF WONDFO COVID-19 RAPID DIAGNOSTIC TEST IN AUSTRALIA
* CELLMID-AUSTRALIA PRODUCT LAUNCH PLANNED FOR MARCH IN PRICELINE HAS BEEN DELAYED, WILL START EFFECTING SALES FROM APRIL ONWARDS LOCALLY
* WILL SEPARATE LYRAMID INTO WHOLLY INDEPENDENT ENTITY BACKED BY INDEPENDENT FUNDING AND/OR PARTNERSHIP WITH BIOPHARMACEUTICAL CO BY 2020 END